- Home
- OCUP vs FMY Comparison
OCUP vs FMY Comparison
Compare OCUP & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCUP
- FMY
- Stock Information
- Founded
- OCUP 2018
- FMY 2005
- Country
- OCUP United States
- FMY United States
- Employees
- OCUP N/A
- FMY N/A
- Industry
- OCUP Biotechnology: Pharmaceutical Preparations
- FMY Finance/Investors Services
- Sector
- OCUP Health Care
- FMY Finance
- Exchange
- OCUP Nasdaq
- FMY Nasdaq
- Market Cap
- OCUP 53.1M
- FMY 52.1M
- IPO Year
- OCUP N/A
- FMY N/A
- Fundamental
- Price
- OCUP $1.27
- FMY $12.45
- Analyst Decision
- OCUP Strong Buy
- FMY
- Analyst Count
- OCUP 3
- FMY 0
- Target Price
- OCUP $18.67
- FMY N/A
- AVG Volume (30 Days)
- OCUP 83.7K
- FMY 10.1K
- Earning Date
- OCUP 11-11-2024
- FMY 01-01-0001
- Dividend Yield
- OCUP N/A
- FMY 6.98%
- EPS Growth
- OCUP N/A
- FMY N/A
- EPS
- OCUP N/A
- FMY N/A
- Revenue
- OCUP $16,449,000.00
- FMY N/A
- Revenue This Year
- OCUP N/A
- FMY N/A
- Revenue Next Year
- OCUP $258.69
- FMY N/A
- P/E Ratio
- OCUP N/A
- FMY N/A
- Revenue Growth
- OCUP N/A
- FMY N/A
- 52 Week Low
- OCUP $1.15
- FMY $10.71
- 52 Week High
- OCUP $3.53
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- OCUP 44.53
- FMY 51.69
- Support Level
- OCUP $1.25
- FMY $12.33
- Resistance Level
- OCUP $1.35
- FMY $12.52
- Average True Range (ATR)
- OCUP 0.08
- FMY 0.15
- MACD
- OCUP 0.00
- FMY -0.01
- Stochastic Oscillator
- OCUP 12.00
- FMY 30.74
About OCUP Ocuphire Pharma Inc.
Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities.